In clear cell renal cell carcinoma (ccRCC), IGF2BP2 stabilizes salt inducible kinase 2 (SIK2) mRNA to enhance autophagic flux via the FTO-mediated m6A modification, diminishing the ccRCC growth and metastasis 59. Here, SIK2 is linked to nonpapillary renal cell carcinoma.